Fig. 2From: Evaluation of the chromogenic anti-factor IIa assay to assess dabigatran exposure in geriatric patients with atrial fibrillation in an outpatient settingBland-Altman plot is shown for dabigatran levels by HPLC MS/MS and chromogenic anti-factor IIa (diff, difference; n = 16)Back to article page